These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20384540)

  • 1. Needed, new paradigms in antibiotic development.
    Ceri H; Olson ME; Turner RJ
    Expert Opin Pharmacother; 2010 Jun; 11(8):1233-7. PubMed ID: 20384540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
    Delissalde F; Amábile-Cuevas CF
    Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection.
    Lopes SP; Ceri H; Azevedo NF; Pereira MO
    Int J Antimicrob Agents; 2012 Sep; 40(3):260-3. PubMed ID: 22770521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and resistance to imipenem of Pseudomonas aeruginosa on latex gloves.
    Ballesta S; Conejo MC; García I; Rodríguez-Martínez JM; Velasco C; Pascual A
    J Antimicrob Chemother; 2006 May; 57(5):1010-2. PubMed ID: 16531426
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.
    Pamp SJ; Gjermansen M; Johansen HK; Tolker-Nielsen T
    Mol Microbiol; 2008 Apr; 68(1):223-40. PubMed ID: 18312276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance.
    Landry RM; An D; Hupp JT; Singh PK; Parsek MR
    Mol Microbiol; 2006 Jan; 59(1):142-51. PubMed ID: 16359324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for testing drug susceptibility of Pseudomonas aeruginosa and Staphylococcus aureus grown in biofilms on medical devices.
    Kétyi I
    Acta Microbiol Immunol Hung; 1995; 42(2):215-9. PubMed ID: 7551716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
    Cross JL; Ramadan HH; Thomas JG
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilms, antimicrobial resistance, and airway infection.
    Prince AS
    N Engl J Med; 2002 Oct; 347(14):1110-1. PubMed ID: 12362015
    [No Abstract]   [Full Text] [Related]  

  • 16. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
    Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
    Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
    Drenkard E; Ausubel FM
    Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Foreign body infections--biofilms and quorum sensing].
    Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
    Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm susceptibility to metal toxicity.
    Harrison JJ; Ceri H; Stremick CA; Turner RJ
    Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression in Pseudomonas aeruginosa biofilms.
    Whiteley M; Bangera MG; Bumgarner RE; Parsek MR; Teitzel GM; Lory S; Greenberg EP
    Nature; 2001 Oct; 413(6858):860-4. PubMed ID: 11677611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.